Advertisement

Topics

ViroLogic Company Profile

10:31 EST 16th February 2019 | BioPortfolio

ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to make rational treatment decisions in the management of viral diseases. The company's proprietary technology is also being used in the fields of viral pharmacogenomics to identify, analyze, and select new drug candidates for treating viral diseases and cancer, and in disease management through the development of therapy guidance algorithms to guide patient therapy. ViroLogic sales representatives have been in the field since November 1999 raising awareness among HIV-treating physicians of phenotypic testing and its benefits.

Location

270 East Grand Avenue
South San Francisco
CA
94080
United States of America


News Articles [14 Associated News Articles listed on BioPortfolio]

The US Domestic Influenza Virologic Surveillance Landscape

The development of a process map characterizing the landscape of US influenza virologic surveillance may help improve pandemic planning and response efforts. Emerging Infectious Diseases

GSK announces results of three year trial into long-lasting HIV injection

GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the HIV Glasgow Drug Therapy meeting in Scotland. The phase IIb LATTE-2...

AbbVie’s Mavyret shows high virologic cure rates in HCV study

The analysis, which is part of the 3b Expedition-8 study, assessed the safety and efficacy of Mavyret in treatment-naïve chronic hepatitis C virus (HCV) patients with compensated cirrhosis The post ...

ViiV's fostemsavir maintains virologic suppression at week 48 in Phase III for HIV

Enanta Announces that AbbVie’s MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic ...

Read more...

Novel Agent for Refractory HIV Patients Hits the Mark

(MedPage Today) -- Fostemsavir maintained virologic response through week 48 in ongoing phase III trial

Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA®▼ (D/C/F/TAF) in Treatment-Naïve Adults with HIV-1

New Phase 3 AMBER study data continues to demonstrate high rates of virologic suppression at 96 weeks in ART-naïve adults with HIV-1 when treated with D/C/F/TAF1 The J...

Detection of HSV and VZV by Molecular Methods

This study compared multiplex nucleic acid amplification tests that detect and differentiate herpes simplex virus and varicella-zoster virus with traditional virologic assays. American Journal of Cl...

Drugs and Medications [12 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN CAPSULES safely and effectively. See full prescribing information for RIBAVIRIN CAPSULES.Ribavirin capsules, for oral useIni...

Lopinavir-ritonavir [lannett company, inc.]

These highlights do not include all the information needed to use use LOPINAVIR AND RITONAVIR ORAL SOLUTION safely and effectively. See full prescribing information for LOPINAVIR AND RITONAVIR ORAL ...

Viekira [abbvie inc.]

These highlights do not include all the information needed to use VIEKIRA XR safely and effectively. See full prescribing information for VIEKIRA XR. VIEKIRA XR (dasabuvir, ombitasvir, paritaprevir, a...

Ribasphere [kadmon pharmaceuticals, llc]

These highlights do not include all the information needed to use RIBASPHERE (ribavirin capsules USP) safely and effectively. See full prescribing information for RIBASPHERE.RIBASPHERE (ribavirin caps...

Viekira pak [abbvie inc.]

These highlights do not include all the information needed to use VIEKIRA PAK safely and effectively. See full prescribing information for VIEKIRA PAK. VIEKIRA PAK (ombitasvir, paritaprevir, and riton...

PubMed Articles [54 Associated PubMed Articles listed on BioPortfolio]

Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.

Access to routine virologic monitoring, critical to ensuring treatment success, remains limited in low- and middle-income countries. We report on implementation of routine viral load (VL) monitoring a...

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.

The 2016 WHO consolidated guidelines on the use of antiretroviral drugs defines HIV virologic failure for low and middle income countries (LMIC) as plasma HIV-RNA ≥ 1000 copies/mL. We evaluated viro...

Correction: Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.

[This corrects the article DOI: 10.1371/journal.pone.0200242.].

RAPID ART: High virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population.

Little is known about long-term viral suppression (VS) rates for patients who start ART soon after diagnosis. We describe virologic outcomes from the San Francisco-based Ward 86 RAPID-ART program.

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection.

Sphingolipids (SLs) have been implicated as potent regulators of the hepatitis B virus (HBV) life cycle. We investigated the SL biomarker potential regarding virologic endpoints in a prospective subgr...

Clinical Trials [269 Associated Clinical Trials listed on BioPortfolio]

Structured Treatment Interruption for HIV Patients With Virologic Failure

The purpose of this study is to assess the virologic impact of switching treatment-experienced HIV-infected patients with virologic failure to a salvage regimen with or without a 12 week S...

Study to Evaluate the Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-infected Subjects Evidencing Virologic Suppression

The main purpose is to explore whether atazanavir/ritonavir (ATV/RTV) single enhanced protease inhibitor therapy can maintain virologic suppression without a marked increase in virologic f...

EXtended Therapy in Hepatitis C Genotype 3 Infected Patients

The purpose of this study is to evaluate the effect of 48 vs 24 weeks of treatment with Peginterferon alfa-2b plus weight-based ribavirin on Sustained Virologic Response (SVR) and relapse ...

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

To elucidate the relationship between virologic risk factors and immunologic and clinical progression in patients receiving monotherapy in protocol ACTG 175, and to compare new treatment r...

Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

This study will evaluate the effect of treatment with 24 weeks nitazoxanide monotherapy on end of treatment virologic response, sustained virologic response, reduction of quantitative seru...

Companies [2 Associated Companies listed on BioPortfolio]

ViroLogic

ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to m...

Adenosine Therapeutics,LLC

Adenosine Therapeutics (AT), located in Charlottesville, VA, is a drug discovery and development company that was co-founded in 1999 by University of Virginia (UVa) Professor, Joel Linden and entrepre...

More Information about "ViroLogic" on BioPortfolio

We have published hundreds of ViroLogic news stories on BioPortfolio along with dozens of ViroLogic Clinical Trials and PubMed Articles about ViroLogic for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ViroLogic Companies in our database. You can also find out about relevant ViroLogic Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record